172 related articles for article (PubMed ID: 9099048)
21. The control of acute cisplatin-induced emesis--a comparative study of granisetron and a combination regimen of high-dose metoclopramide and dexamethasone. Granisetron Study Group.
Chevallier B
Br J Cancer; 1993 Jul; 68(1):176-80. PubMed ID: 8391304
[TBL] [Abstract][Full Text] [Related]
22. A double-blind randomized study comparing intramuscular (i.m.) granisetron with i.m. granisetron plus dexamethasone in the prevention of delayed emesis induced by cisplatin. The Italian Multicenter Study Group.
Anticancer Drugs; 1999 Jun; 10(5):465-70. PubMed ID: 10477166
[TBL] [Abstract][Full Text] [Related]
23. A randomised, double-blind comparison of granisetron with high-dose metoclopramide, dexamethasone and diphenhydramine for cisplatin-induced emesis. An NCI Canada Clinical Trials Group Phase III Trial.
Warr D; Wilan A; Venner P; Pater J; Kaizer L; Laberge F; Latreille J; Stewart D; O'Connell G; Osoba D
Eur J Cancer; 1992; 29A(1):33-6. PubMed ID: 1332737
[TBL] [Abstract][Full Text] [Related]
24. Low-dose oral granisetron (1 mg) plus intravenous dexamethasone: efficacy in gynecologic cancer patients receiving carboplatin-based chemotherapy.
Markman M; Kennedy A; Webster K; Kulp B; Peterson G; Belinson J
Gynecol Oncol; 1998 Oct; 71(1):113-5. PubMed ID: 9784330
[TBL] [Abstract][Full Text] [Related]
25. Prevention of cisplatin-induced delayed emesis: still unsatisfactory. Italian Group for Antiemetic Research.
Support Care Cancer; 2000 May; 8(3):229-32. PubMed ID: 10789965
[TBL] [Abstract][Full Text] [Related]
26. [Comparison of granisetron alone and granisetron plus dexamethasone or hydroxyzine hydrochloride for the prevention of nausea and vomiting during chemotherapy including cisplatin].
Tsukuda M; Kohno H; Enomoto H; Kawai S; Yago T; Matsuda H; Ikema Y; Makino Y; Kubota A; Furukawa M
Gan To Kagaku Ryoho; 1995 Sep; 22(10):1377-82. PubMed ID: 7668873
[TBL] [Abstract][Full Text] [Related]
27. Comparison of tropisetron and granisetron in the control of nausea and vomiting in children receiving combined cancer chemotherapy.
Aksoylar S; Akman SA; Ozgenç F; Kansoy S
Pediatr Hematol Oncol; 2001 Sep; 18(6):397-406. PubMed ID: 11554235
[TBL] [Abstract][Full Text] [Related]
28. A report comparing the use of tropisetron (Navoban), a 5-HT3 antagonist, with a standard antiemetic regimen of dexamethasone and metoclopramide in cisplatin-treated patients under conditions of severe emesis.
Madej G; Krzakowski M; Pawinski A; Lasota W; Rogowski W; Skoneczna I
Semin Oncol; 1994 Oct; 21(5 Suppl 9):3-6. PubMed ID: 9113119
[TBL] [Abstract][Full Text] [Related]
29. Contribution to the treatment of nausea and emesis induced by chemotherapy in children and adolescents with osteosarcoma.
Luisi FA; Petrilli AS; Tanaka C; Caran EM
Sao Paulo Med J; 2006 Mar; 124(2):61-5. PubMed ID: 16878187
[TBL] [Abstract][Full Text] [Related]
30. The efficacy of granisetron for cancer patients undergoing platinum-based chemotherapy: comparison of 1 miligram versus 3 miligram doses in preventing nausea and vomiting.
Kurnianda J; Hisyam B; Wahyuningsih E; Hutajulu SH
Acta Med Indones; 2005; 37(4):210-3. PubMed ID: 16317218
[TBL] [Abstract][Full Text] [Related]
31. Comparison of ondansetron with metoclopramide in prevention of acute emesis associated with low dose & high dose cisplatin chemotherapy.
Bhatia A; Tripathi KD; Sharma M
Indian J Med Res; 2003 Jul; 118():33-41. PubMed ID: 14748464
[TBL] [Abstract][Full Text] [Related]
32. Cost-effectiveness analysis of granisetron-based versus standard antiemetic regimens in low-emetogenic chemotherapy: a hospital-based perspective from Malaysia.
Keat CH; Ghani NA
Asian Pac J Cancer Prev; 2013; 14(12):7701-6. PubMed ID: 24460356
[TBL] [Abstract][Full Text] [Related]
33. Superiority of granisetron to dexamethasone plus prochlorperazine in the prevention of chemotherapy-induced emesis.
Warr D; Willan A; Fine S; Wilson K; Davis A; Erlichman C; Rusthoven J; Lofters W; Osoba D; Laberge F
J Natl Cancer Inst; 1991 Aug; 83(16):1169-73. PubMed ID: 1653363
[TBL] [Abstract][Full Text] [Related]
34. A randomized cross-over study of high-dose metoclopramide plus dexamethasone versus granisetron plus dexamethasone in patients receiving chemotherapy with high-dose cisplatin.
Ohmatsu H; Eguchi K; Shinkai T; Tamura T; Ohe Y; Nisio M; Kunikane H; Arioka H; Karato A; Nakashima H
Jpn J Cancer Res; 1994 Nov; 85(11):1151-8. PubMed ID: 7829401
[TBL] [Abstract][Full Text] [Related]
35. [Comparative trial of granisetron versus granisetron plus methylprednisolone for the prevention of nausea and vomiting induced by cancer chemotherapy].
Hirota T; Shimizu H; Fujimoto T; Koike A; Kojima T; Noguchi M; Yabushita H; Kato R; Daimaru O; Noda A
Gan To Kagaku Ryoho; 1994 Jan; 21(1):91-6. PubMed ID: 8291920
[TBL] [Abstract][Full Text] [Related]
36. Randomized, multicenter comparison of oral granisetron and oral ondansetron for emetogenic chemotherapy.
Herrington JD; Kwan P; Young RR; Lagow E; Lagrone L; Riggs MW
Pharmacotherapy; 2000 Nov; 20(11):1318-23. PubMed ID: 11079280
[TBL] [Abstract][Full Text] [Related]
37. Midazolam for acute emesis refractory to dexamethasone and granisetron after highly emetogenic chemotherapy: a phase II study.
Mandalà M; Cremonesi M; Rocca A; Cazzaniga M; Ferretti G; Di Cosimo S; Ghilardi M; Cabiddu M; Barni S
Support Care Cancer; 2005 Jun; 13(6):375-80. PubMed ID: 15668754
[TBL] [Abstract][Full Text] [Related]
38. Comparative efficacy of oral and intravenous granisetron for the prevention of acute chemotherapy-induced emesis.
Perez EA
Clin Ther; 1996; 18(4):578-90; discussion 577. PubMed ID: 8879888
[TBL] [Abstract][Full Text] [Related]
39. A double-blind comparison of the efficacy of two dose regimens of oral granisetron in preventing acute emesis in patients receiving moderately emetogenic chemotherapy.
Ettinger DS; Eisenberg PD; Fitts D; Friedman C; Wilson-Lynch K; Yocom K
Cancer; 1996 Jul; 78(1):144-51. PubMed ID: 8646710
[TBL] [Abstract][Full Text] [Related]
40. The influence of dexamethasone in the decrease of chemotherapy-induced nausea and vomiting.
Sarcev T; Secen N; Povazan Dj; Sabo A; Popovic J; Bursac D; Kakas M; Zaric B; Milovancev A
J BUON; 2007; 12(2):245-52. PubMed ID: 17600880
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]